Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...

A low-carbohydrate (low-carb) diet restricts things like pasta, bread, and sugary foods. Here’s why you might consider the ...

A potential $4 billion licensing deal with Vor Bio triggered a slide in RemeGen's stock price. Otsuka obtained a BCMAXCD3 ...

Four out of 10 U.S. adults ages 18 to 44 have insulin resistance—and most don’t even know it. But what is insulin resistance, ...

Almost two years after a near fatal stroke, Greg Burton's recovery is being described as miraculous. Now the Burtons share a ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

For these people, doctors often recommend tests once a year or more frequently if needed. A study published in BMJ Open found ...

The most common risk factors for stroke include high blood pressure, high cholesterol, diabetes, smoking, obesity, and ...